In a statement issued late on Friday, Medtronic said: “For Astra pacemaker, Solara CRT-P and Serena CRT-P models we are communicating proactively with the doctors and relevant stakeholders in India and have informed them about the performance note. Medtronic’s apparent neglect comes close on the heels of the Johnson & Johnson faulty hip implant case, where loopholes in the Indian medical device regulatory laws were used to push sub-standard products into the country. This exposes our patients to abuse and exploitation,’’ said a senior Health Ministry official. “Currently, in India, medical devices don’t come under the notified category, which basically means that devices can be imported from anywhere and used in India. We will be moving court against the company for harassment and fraud after my father’s surgery,” said Sunil Kumar, Mr. Medtronic was informed about the faulty device but they refused to replace it or pay compensation. “Shocked and perplexed, we have no option but to get a replacement to help my father stay alive. Singh’s heart beating had drained, requiring immediate change for him to stay alive. His 2015 CRT-D advanced pacemaker manufactured by Medtronic, with a promised battery life of 7 to 11 years, packed up in four years this Wednesday. “This is just not enough,” said retired State Bank of India (SBI) employee Chander Singh, currently admitted at a super specialty private hospital in north India for the replacement of his Medtronic pacemaker. We may soon come up with a public information/announcement about the problem.” ‘Not enough’ We have received a reply from them and it is being processed. We have written to Medtronic asking them for details on how many of the allegedly defective products have been sold, and their position here in India. Eswara Reddy, Drug Controller General of India, said, “We are aware of the May 7 FDA alert on Medtronic pacemakers and its adverse effect on our patients. His unit is currently dealing with at least nine patients who have returned for battery replacement, “a direct fall-out of this criminal neglect,” said Dr. “In fact, all these models are still doing brisk business in India,” said cardiologist Dr. However, this was never communicated by the company to medical professionals here, confirmed Indian doctors and senior Health Ministry officials.
This included pacemaker models named Azure, Astra, Percepta, Serena and Solara CRT-Ds (Cardiac Resynchronisation Therapy-Defibrillator) such as Amplia and ICDs (implantable cardioverter defibrillators) such as Evera. Food and Drug Administration (FDA) issued warnings and recalled recalled some pacemakers manufactured and sold by Medtronic in that country after problems were detected in the device. On May 7, and in January 2019, along with a similar recall in January 2018, the U.S. In India, pacemakers cost between ₹1 lakh to ₹9 lakh, with batteries that last on average between 7-10 years.
Medtronic, Abbott, Boston Scientific and Biotronik manufacture the leading pacemaker brands in India. This puts thousands of heart patients at risk of a sudden death caused by premature battery depletion in their Medtronic pacemakers.Ī pacemaker is an implantable, battery-powered minicomputer that sends electrical pulses to the heart whenever it detects a slow heartbeat or no heartbeat at all. The world’s largest medical device manufacturer, Medtronic, appears to have decided to remain silent and continue selling its allegedly defective pacemakers in India.
0 kommentar(er)
